316 related articles for article (PubMed ID: 10184748)
1. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
Snape WJ
Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
Dajani EZ
J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
[TBL] [Abstract][Full Text] [Related]
3. Prokinetic therapy in gastroesophageal reflux disease.
Champion MC
Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux in infants and children.
Jung AD
Am Fam Physician; 2001 Dec; 64(11):1853-60. PubMed ID: 11764863
[TBL] [Abstract][Full Text] [Related]
5. Individualized acute treatment strategies for gastroesophageal reflux disease.
Reynolds JC
Scand J Gastroenterol Suppl; 1995; 213():17-24. PubMed ID: 8578239
[TBL] [Abstract][Full Text] [Related]
6. The pharmacological management of gastroesophageal reflux disease.
Lowe RC; Wolfe MM
Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
[TBL] [Abstract][Full Text] [Related]
7. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
[TBL] [Abstract][Full Text] [Related]
8. Prokinetic therapy for gastroesophageal reflux disease.
Robinson M
Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of extraesophageal gastroesophageal reflux disease.
Katz PO
J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
[TBL] [Abstract][Full Text] [Related]
10. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
11. Current management of gastroesophageal reflux disease.
DeVault KR
Gastroenterologist; 1996 Mar; 4(1):24-32. PubMed ID: 8689142
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease: diagnosis and management.
Scott M; Gelhot AR
Am Fam Physician; 1999 Mar; 59(5):1161-9, 1199. PubMed ID: 10088873
[TBL] [Abstract][Full Text] [Related]
13. [A new prokinetic drug cisapride: pharmacological properties and clinical potential].
Sheptulin AA; Muradov NN
Klin Med (Mosk); 1997; 75(7):53-6. PubMed ID: 9411058
[No Abstract] [Full Text] [Related]
14. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
15. Contemporary medical therapy for gastroesophageal reflux disease.
Fass R; Hixson LJ; Ciccolo ML; Gordon P; Hunter G; Rappaport W
Am Fam Physician; 1997 Jan; 55(1):205-12, 217-8. PubMed ID: 9012279
[TBL] [Abstract][Full Text] [Related]
16. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
18. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
Nandurkar S
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
[No Abstract] [Full Text] [Related]
19. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
Halter F; Staub P; Hammer B; Guyot J; Miazza BM
J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
[TBL] [Abstract][Full Text] [Related]
20. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
